Form 4 for ZION ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
Accepted 2026-02-09 00:00:00 ET · period of report 2026-02-06 · accession 0000109380-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-09 | 2026-02-06 | ZION | STEPHENS STEVEN DAN | EVP, Division CEO | M - OptEx | $48.44 | +13.6K | 43.2K | +46% | +$658.0K |
| DM | 2026-02-09 | 2026-02-06 | ZION | STEPHENS STEVEN DAN | EVP, Division CEO | S - Sale+OE | $65.90 | -15.5K | 43.2K | -26% | -$1.02M |
| DM | 2026-02-09 | 2026-02-06 | ZION | STEPHENS STEVEN DAN | EVP, Division CEO | M - OptEx | $48.44 | -13.6K | 2,190 | -86% | -$658.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | M | A | 4,769 | $51.17 | 48,002 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-06 | M | A | 6,707 | $45.65 | 49,940 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-06 | S | D | 6,707 | $65.90 | 43,233 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $65.89 to $65.95. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. |
| 4 | Common | Common Stock | 2026-02-06 | M | A | 2,106 | $51.17 | 43,233 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-06 | S | D | 4,000 | $65.91 | 41,127 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-06 | S | D | 4,769 | $65.90 | 43,233 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $65.88 to $65.95. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. |
| 7 | Derivative | Stock Option (right to buy) | 2026-02-06 | M | D | 2,106 | $51.17 | 4,769 | D | $51.17 · — to 2026-02-28 | 2,106 Common Stock | (F3) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |
| 8 | Derivative | Stock Option (right to buy) | 2026-02-06 | M | D | 4,769 | $51.17 | 0 | D | $51.17 · — to 2026-02-28 | 4,769 Common Stock | (F3) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |
| 9 | Derivative | Stock Option (right to buy) | 2026-02-06 | M | D | 6,707 | $45.65 | 2,190 | D | $45.65 · — to 2027-02-09 | 6,707 Common Stock | (F3) Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. |